Wednesday, 8 November 2017

Drugmaker Regeneron's quarterly profit surges 47 percent

(Reuters) - Regeneron Pharmaceuticals Inc reported a 47 percent jump in quarterly profit on Wednesday on higher demand for its flagship eye treatment Eylea.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)